NEWS

News

Smart4Fabry final workshop on 3 February 2021

 

Join the Smart4Fabry Final Workshop to learn from expert speakers how, why and for what the solution proposed by Smart4Fabry was conceived, a sign of cooperation at European level to boost nanomedicine development and translation to clinical stages.

Smart4Fabry is the acronym of a H2020 funded Project that stands for “Smart functional GLA-nanoformulation for Fabry disease”. Smart4Fabry is a collaborative project funded under the H2020 EU Research and Innovation programmecoordinated by Nora Ventosa, from the Nanomol Group at Institut de Ciència de Materials de Barcelona (ICMAB-CSIC). Other CSIC and CIBER-BBN groups participate, like the group of Fernando Albericio (IRB), Simó Schwartz (Vall d'Hebron) and Antonio Villaverde (IBB).

Smart4Fabry is about Fabry disease, a rare disease. Rare diseases mean a major health problem for a significant number of people in total, but affecting small number of patients for each individual disease.

The project is conceived and created to obtain a new nanoformulation of GLA, to improve the efficacy and toleration compared to the actual treatment with non-formulated GLA. The final benefit is to see a considerable reduction on the Fabry disease treatment cost and a substantial improvement in the life-quality of Fabry disease patients.

Smart-4-Fabry has an impact on a major health problem, the existence of new therapies for rare diseases, which constitutes a priority societal challenge as shown in the H2020 Work Programmes.

Smart4Fabry workshop

This workshop will take place on 3 February at 2 pm, online. to register, visit the Smart4Fabry workshop website

The programmee includes a talk by Nora Ventosa, ICMAB researcher and project coordinator, on "Smart4Fabry project: A European joint effort to use nanotechnology in Enzymatic Replacement Therapy development". 

Elisabet González, also ICMAB researcher at Nanomol, will give the talk "Optimizing the nanoformulation: a long trip from lab to reality" along with Míriam Royo, from IQAC-CSIC. 

The workshop also includes a round table on "Open innovation, exploitation and business development" with the participation of Ángel del Pozo (Biokeralty), Andreu Soldevila (Leanbiopro), Santi Sala (Nanomol Technologies) - Andreas Falk (BioNanoNet Forschungsgesellschaft mbH (BNN)).

 

VIDEO: Smart-4-Fabry - Innovation to improve the quality of life of Fabry disease patients: 

https://www.youtube.com/watch?v=H6om9LbeMjg&t=70s&ab_channel=PixVideosProductionCompany

 

The link to register is: https://smart4fabry.cientifis.com/ 

 

Lídia Ballell, Poster Prize at the SCN2 II Annual Conference of Nanomedicine

 lidia-ballell-scn2-170ce5e9.jpeg

Lídia Ballell, PhD fellow doing her research between the Nanomol Group at ICMAB and the company Nanomol Technologies, won the Poster Prize award at the SCN2 II Annual Conference of Nanoscience and Nanotechnology celebrated on 19 November 2020 and focused on the latest advances on nanobiomedicine. Lídia Ballell's poster was entitled "Delos nanovesicles for drug delivery: an example of reformulation of a protein to treat complex wounds". 

Lídia Ballell is at present developing an Industrial Doctorate between the Nanomol Group at the Institute of Materials Science of Barcelona (ICMAB-CSIC) and the company Nanomol Technologies S.L, where she is one of R&D Scientists. She is in charge of the production and characterization of different nanovesicle prototypes in R&D projects. Lídia has an MSc in Drug Research, Development and Control at the University of Barcelona and a bachelor’s degree in Nanoscience and Nanotechnology from the Universitat Autònoma de Barcelona (UAB).

Researchers from the Nanomol Group initiate contacts with the Spanish Agency for Medicines and Health Products (AEMPS) to bring a new treatment against venous leg ulcers to clinical practice

Researchers of the Nanomol group of the Institute of Materials Science of Barcelona (ICMAB-CSIC), together with the company Nanomol Technologies S.L. have begun a consultation process with the Spanish Association of Medicines and Health Products (AEMPS) to try and enter a new treatment in a clinical studies stage, to fight against venous ulcers in lower extremities. The study is carried out within the framework of the RIS3CAT NANONAFRES project.

Read more: Researchers from the Nanomol Group initiate contacts with the Spanish Agency for Medicines and...

José Vidal participates at the "V Scientific Day" at the INS Mercè Rodoreda

On Friday, 15 March 2019, the secondary school INS Mercè Rodoreda (Hospitalet de Llobregat) celebrated their "V Scientific Day" (V Jornada Científica) with scientific activities for their students, from 1st ESO to 2nd BTX. José Vidal-Gancedo, Reseracher at ICMAB, was one of the invited speakers. He had the big challenge of talking about "Organic radicals for biomedical applications" to 3rd and 4th ESO students.

Read more: José Vidal participates at the "V Scientific Day" at the INS Mercè Rodoreda

Jornadas DVS/IGC en Madrid y Barcelona

IESMAT, S.A. en colaboración con Nanomol Technologies S.L., el Insitituto de Ciencias de Materiales de Barcelona (ICMAB-CSIC), el centro de Investigación Biomédica en Red (CIBER) y Surface Measurements Systems (SMS) organiza una Jornada Científico-Teórico/Práctica sobre: Sorción Dinámica de Vapores (DVS - Dynamic Vapor Sorption) y caracterización de materiales (iCG-SEA Inverse Gas Chromatography/Surface Energy Analyzer) para el análisis de la sorción de agua y vapores orgánicos, y caracterización de materiales y superfícies.

Read more: Jornadas DVS/IGC en Madrid y Barcelona